These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1233823)

  • 21. Clinical and biochemical studies on obese subjects using fenfluramine.
    Abdel-Kader MM; Mashaly M; Abdel-Aziz MT
    J Egypt Med Assoc; 1974; 57(9-10):433-41. PubMed ID: 4452780
    [No Abstract]   [Full Text] [Related]  

  • 22. [Psychiatric complications in the treatment of obesity using fenfluramine].
    Klompenhouwer JL; Stricker BH; van Tilburg AJ; Moleman P; Pepplinkhuizen L
    Ned Tijdschr Geneeskd; 1988 Nov; 132(46):2114-7. PubMed ID: 3205320
    [No Abstract]   [Full Text] [Related]  

  • 23. Fenfluramine in the treatment of hypertensive patients with refractory obesity.
    Scott ME; Nelson PG
    Ulster Med J; 1975; 44(1):56-61. PubMed ID: 1124562
    [No Abstract]   [Full Text] [Related]  

  • 24. [A multicenter open study of dexfenfluramine in Italy. The efficacy and safety of using dexfenfluramine in treating patients with simple or complicated obesity. The DIMOS Group].
    Enzi G
    Ter Arkh; 1997; 69(5):71-5. PubMed ID: 9235665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind clinical trial of fenfluramine in the treatment of obesity.
    Sainani GS; Fulambarkar AM; Khurana BK
    Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636
    [No Abstract]   [Full Text] [Related]  

  • 27. Weighing benefits and risks of drug to treat obesity.
    Sukkari SR
    CMAJ; 1997 Mar; 156(6):768-9. PubMed ID: 9084379
    [No Abstract]   [Full Text] [Related]  

  • 28. The anorectic and hypotensive effect of fenfluramine in obesity.
    Hudson KD
    J R Coll Gen Pract; 1977 Aug; 27(181):497-501. PubMed ID: 616838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overweight, obesity, and blood pressure: the effects of modest weight reduction.
    Mertens IL; Van Gaal LF
    Obes Res; 2000 May; 8(3):270-8. PubMed ID: 10832771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fenfluramine in the management of obesity.
    Datey KK; Kelkar PN; Pandya RS
    Br J Clin Pract; 1973 Oct; 27(10):373-5. PubMed ID: 4601613
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of gastric bypass surgery on hypertension in morbidly obese patients.
    Carson JL; Ruddy ME; Duff AE; Holmes NJ; Cody RP; Brolin RE
    Arch Intern Med; 1994 Jan; 154(2):193-200. PubMed ID: 8285814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anorexigen-induced cardiac valvulopathy and female gender.
    Naqvi TZ; Gross SB
    Curr Womens Health Rep; 2003 Apr; 3(2):116-25. PubMed ID: 12628081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observed factors responsible for resistant hypertension in a teaching hospital setting.
    Salako BL; Ayodele OE
    Afr J Med Med Sci; 2003 Jun; 32(2):151-4. PubMed ID: 15032461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment with fenfluramine in obese subjects.
    Sensi S; Della Loggia F; Del Ponte A; Guagnano MT
    Int J Clin Pharmacol Res; 1985; 5(4):247-53. PubMed ID: 4055167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind clinical trial of fenfluramine.
    Lele RD; Joshi VR; Nathwani AN
    Br J Clin Pract; 1972 Feb; 26(2):79-82. PubMed ID: 4552745
    [No Abstract]   [Full Text] [Related]  

  • 37. [Oral contraceptives and arterial hypertension].
    Losse H; Risse E; Wessels F
    Med Klin; 1974 Dec; 69(50):2043-50. PubMed ID: 4374645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of weight reduction on blood pressure in 301 obese patients.
    Schotte DE; Stunkard AJ
    Arch Intern Med; 1990 Aug; 150(8):1701-4. PubMed ID: 2383165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription weight loss pill use among Americans: patterns of pill use and lessons learned from the fen-phen market withdrawal.
    Blanck HM; Khan LK; Serdula MK
    Prev Med; 2004 Dec; 39(6):1243-8. PubMed ID: 15539063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The treatment of the obese non-insulin-dependent patient with d-fenfluramine].
    Daniele E; Coco MP
    Clin Ter; 1996 Apr; 147(4):199-204. PubMed ID: 8766352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.